
شيماء
@_shwarms
ID: 1317078348259098624
16-10-2020 12:22:53
86 Tweet
47 Followers
103 Following











The CATIS-ICAD trial established that use of low-dose rivaroxaban added to aspirin was feasible, low risk, and potentially efficacious, setting the groundwork for a future efficacy trial. Sashi Perera, MD Aristeidis Katsanos Ashkan Shoamanesh PHRI.ca Population Health Research Institute 🇨🇦 McMaster University Department of Medicine ahajrnls.org/3Cb1K5A






